This event at the Novartis Campus in Basel brings together scientists and professionals involved in the research, development, and manufacture of drug-device combination products for parenteral use. Covering technologies such as autoinjectors, prefilled syringes, wearable devices, and connected systems, the program addresses topics ranging from formulation and device development to regulatory landscape, sustainability, and high-dose delivery.
Ypsomed’s Jakob Lange will join a panel discussion on high-volume injections, focusing on current status and supply challenges in this rapidly evolving area of drug delivery.
Make sure to attend the panel on June 10 to gain insights into the realities of high-volume injection development and supply.
Our speaker at the conference
Jakob Lange
Head of Marketing & Sales
- Topic: Panel discussion "High-volume injections" – status updates and supply challenges
- Date & time: 10 June
